Regulatory
Scientific Exchange vs Promotion: 6 Clear Lines to Hold
Scientific exchange is how a product company discusses the science with physicians without making a sales claim. Promotion
Oscar Tellez
October 28, 2026
The Latest Industry Updates
Read the full post
Clinic Growth
Practice Valuation for Regen Clinics: 8 Practical Value Drivers
A buyer, a partner, or a lender will one day ask what your practice is worth. Practice valuation
Oscar Tellez
October 27, 2026
Regulatory
KOL Program Rules: 8 Clear Steps for Regen Product Companies
A physician who respects your product can carry more weight with other doctors than a rep. That is
Oscar Tellez
October 26, 2026
Regulatory
Medical Board Advertising Rules: 6 Clear Traps to Avoid
Most regen practices review their marketing against the FDA and the FTC and stop there. Medical board advertising
Oscar Tellez
October 23, 2026
Regulatory
Regen Clinic Staffing: 5 Clear Rules for Credential Claims
Regen clinic staffing pages carry more legal weight than most owners think. The bio, the team page, and
Oscar Tellez
October 22, 2026
Regulatory
Clinic Compliance Program: A Practical 30-Day Build Plan
Most practices treat compliance as a one-time cleanup. A clinic compliance program is different. It is the standing
Oscar Tellez
October 21, 2026
Regulatory
Enforcement Watch October 2026: 7 Clear Company Lessons
Every product company in regenerative medicine sells into a market the FDA and the FTC are reading. This
Oscar Tellez
October 20, 2026
Clinic Growth
Front Desk AI Policy: 7 Clear Rules Before Staff Use It
Front desk AI is already inside your practice, whether you set it up or not. Staff draft replies,
Oscar Tellez
October 19, 2026
Regulatory
Peptide Marketing in 2026: 7 Clear Rules for Clinics
Peptide marketing is the question every clinic, compounder and distributor is asking this quarter. The status answer now
Oscar Tellez
October 16, 2026